David John Sugarbaker
Sugarbaker, David J.
Sugarbaker, David J. 1953-
Sugarbaker, David J., 1953-2018
VIAF ID: 16431103 (Personal)
Permalink: http://viaf.org/viaf/16431103
Preferred Forms
- 100 0 _ ‡a David John Sugarbaker
- 100 1 _ ‡a Sugarbaker, David J
- 100 1 _ ‡a Sugarbaker, David J.
-
-
-
-
-
- 100 1 _ ‡a Sugarbaker, David J. ‡d 1953-
- 100 1 _ ‡a Sugarbaker, David J. ‡d 1953-
- 100 1 _ ‡a Sugarbaker, David J., ‡d 1953-2018
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Adult chest surgery | |
Gene expression ratio test distinguishes normal lung from lung tumors in solid tissue and FNA biopsies | |
Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features. | |
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis | |
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. | |
The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura | |
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma | |
Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging | |
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma | |
Innovative therapies: intraoperative intracavitary chemotherapy | |
Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer | |
Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma | |
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1. | |
Interatrial shunting after major thoracic surgery: a rare but clinically significant event | |
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. | |
Lobectomy versus sublobar resection for small | |
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer | |
Lung resection in patients with preoperative FEV1 < 35% predicted | |
Lung volume reduction surgery for emphysema | |
Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient | |
Malignant pleural mesothelioma: overview of the North American and European experience | |
Management of High-Throughput DNA Sequencing Projects: Alpheus | |
The MARS feasibility trial: conclusions not supported by data | |
Matrix metalloproteinase 12 promotes tumor propagation in the lung. | |
Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study | |
Missense mutations of the BRAF gene in human lung adenocarcinoma. | |
Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma | |
Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program | |
MR imaging of benign and malignant pleural disease | |
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids | |
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma | |
Multimodality therapy of chest malignancies : proceedings of a Harvard Medical School symposium | |
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA | |
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion | |
Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. | |
Perioperative Ischemic Optic Neuropathy Following Extrapleural Pneumonectomy. | |
Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies | |
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma | |
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion | |
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | |
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma | |
Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience | |
Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial | |
Postoperative Chylothorax after Thoracoabdominal Aortic Aneurysm Repair. | |
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma | |
Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. | |
Preoperative pulmonary vascular morphology and its relationship to postpneumonectomy hemodynamics | |
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens | |
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies | |
Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages | |
Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803. | |
Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients | |
Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. | |
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma | |
Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. | |
Resection of giant thoracic teratoma [VR] 1991: | |
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. | |
Section V: techniques of esophageal resection | |
Semi-supervised recursively partitioned mixture models for identifying cancer subtypes | |
Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. | |
Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. | |
Surgery for early stage non‐small cell lung cancer | |
Surgical interventions for emphysema | |
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma | |
Transcriptome sequencing of malignant pleural mesothelioma tumors | |
Transhiatal esophagectomy after previous right pneumonectomy. | |
Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma | |
Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma | |
Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery | |
Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma | |
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer | |
Validation of genomics-based prognostic tests in malignant pleural mesothelioma | |
VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance). | |
VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study | |
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. | |
Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. | |
Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression |